🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07445269
Enrolling by invitation Not applicable

ACUTE EFFECTS OF INSPIRATORY MUSCLE WARM-UP ON INSPIRATORY MUSCLE STRENGTH DURING AEROBIC AND ANAEROBIC EXERCISE IN ATHLETES

NCT07445269 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-02-25
Last updated
2026-03-03

Condition(s) studied

Healthy Participants

Investigational drug(s) / intervention(s)

Inspiratory Muscle Warm-Up (40% MIP)Placebo Breathing Warm-Up (15% MIP)

Inspiratory Muscle Warm-Up (40% MIP): A standardized inspiratory muscle warm-up performed using a breathing resistance device set at 40% of maximal inspiratory pressure (MIP). Participants perform resisted inspiratory efforts prior to exercise to acutely activate respiratory muscles.

Placebo Breathing Warm-Up (15% MIP): A sham breathing warm-up performed using the same device and breathing pattern as the active intervention but with resistance set at 15% of maximal inspiratory pressure (MIP), intended to minimize physiological loading while maintaining procedural similarity.

Study summary

Inspiratory muscle warm-up (IMW) is a specific pre-exercise breathing intervention designed to prepare the respiratory muscles before physical activity and potentially enhance exercise performance. Previous research suggests that IMW may acutely improve inspiratory muscle function; however, the duration of these effects during exercise and their responses under different exercise intensities remain unclear. Furthermore, placebo-controlled comparisons are limited in the current literature.

The purpose of this study is to investigate the acute effects of inspiratory muscle warm-up on inspiratory muscle strength during aerobic and anaerobic exercise in trained athletes. The study will compare three experimental conditions: a standardized inspiratory muscle warm-up protocol, a placebo breathing warm-up, and a control condition without respiratory warm-up.

In this repeated-measures interventional study, trained athletes aged 14-30 years will complete three experimental sessions in randomized order. The active intervention consists of inspiratory muscle warm-up performed at 40% of maximal inspiratory pressure (MIP). The placebo condition includes a low-resistance breathing protocol designed to mimic the intervention without providing a meaningful training stimulus. The control condition involves exercise performed without respiratory warm-up.

Participants will perform treadmill exercise at intensity levels representing aerobic and anaerobic workloads, defined according to percentage of maximal heart rate. Inspiratory muscle strength (MIP) will be assessed at baseline, immediately after the warm-up protocols, and periodically during exercise to evaluate time-dependent changes.

The primary objective is to determine how long the acute increase in inspiratory muscle strength is maintained during exercise and to compare responses between aerobic and anaerobic athletes across the three conditions. The findings may provide evidence-based guidance for integrating respiratory muscle warm-up strategies into sport-specific preparation routines.

Eligibility

Sex
ALL
Min age
14 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age between 14 and 30 years. * Regular participation in organized sports training for at least 4 years. * Engaged in predominantly aerobic or anaerobic sports disciplines. * Training frequency of at least 3 sessions per week. * No known cardiopulmonary disease affecting respiratory function. * Ability to safely perform maximal effort treadmill exercise. * No respiratory illness within the last 12 weeks. * Willingness to comply with study procedures. * Provision of written informed consent (and parental consent for minors where applicable). Exclusion Criteria: * History of asthma, chronic obstructive pulmonary disease (COPD), or other respiratory disorders. * Age below 14 years or above 30 years. * Orthopedic injury or condition limiting running ability. * Participation in inspiratory muscle training within the last 12 months. * Use of medications affecting respiratory or cardiovascular function. * Active smoking. * Failure to provide informed consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hitit University Faculty of Sport Sciences, Exercise Physiology Laboratory Çorum Turkey (Türkiye)

More Hitit University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07445269 on ClinicalTrials.gov ↗ ← All trials in Turkey